MedTrace Logo

Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease

NCT01007578 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2023-09-21

No results posted yet for this study

Summary

The purpose of this study is to determine plasma levels of paclitaxel and catheter tolerability subsequent to treating patients with peripheral arterial occlusive disease (PAOD) with paclitaxel-coated balloon catheters.

Conditions

  • Peripheral Arterial Disease
  • Stenotic Femoro-popliteal Arteries
  • Occluded Femoro-popliteal Arteries
  • Atherosclerosis

Interventions

DEVICE

Paclitaxel-coated balloon catheter angioplasty

Paclitaxel-coated balloon catheters for the treatment of peripheral arterial occlusive disease (POAD) of the femoro-popliteal arteries

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-15
Primary Completion
2007-12-15
Completion
2007-12-15

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01007578 on ClinicalTrials.gov